Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Master Agreement

o The Company and TPL will cause certain of their respective interests in the Patents to be licensed to a limited liability company that will be owned 50% by the Company and 50% by TPL (the "JV LLC").

 

I believe that this clause facilitates a sale of PDS subject to variation of the terms.

 

 

Be well

Share
New Message
Please login to post a reply